Skip to content

Clinical Equivalency Validation Protocol Clinical Equivalency Eyenez Retina Camera v200 and Optomed Smartscope M5 EY3

Clinical Equivalency Validation Protocol Eyenez v200 and Volk Pictor Ret1

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02783807
Enrollment
34
Registered
2016-05-26
Start date
2015-10-31
Completion date
2016-05-31
Last updated
2016-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Brief summary

This prospective equivalency study compares the performance of two Ophthalmic Cameras, the Eyenez Retina Ophthalmic Camera v200 (OC) and the Optomed Smartscope M5 EY3 (OP). Trained technicians will take pictures of the same patients' retinas and the quality of the photos will be evaluated. The study includes healthy patients and patients with a spectrum of retinal diseases. The study requires that technicians take pictures of the retinas of adult patients between 18 and 80 years of age using both the OC and OP. The pictures will be reviewed and compared by a central reader/Ophthalmologist, who will determine if the OC is equivalent to the OP, based on the quality of the images

Detailed description

Subjects (patients) will be recruited via word of mouth. The study duration will be approximately 1-2 weeks, assuming a recruitment rate of 15 subjects per week. The images will be recorded within 15 minutes and will involve minimal disruption to the clinical workflow. In the Study Environment setting (Foothill Medical Offices), the User Interface will be evaluated by comparing retinal pictures taken with subject device OC and predicate device OP. Patient subjects will be given an Information and Consent Form to complete prior to the study The technicians employed by Foothill Eye Clinic will operate the device on patient participants by taking a retinal picture using OC. The technicians will use the predicate device OP to take retinal pictures. The Ophthalmologist will compare the results with the pictures taken by OC and OP. The Ophthalmologist will be blinded to what picture was taken by which camera and record his assessment of the quality for each picture. Patient subjects will receive a standard of care exam with or without dilation.

Interventions

DEVICEEyenez Retinal Camera v200
DEVICEVolk Pictor Ret 1

Sponsors

Eyenez LLC
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

Healthy subjects Inclusion Criteria: * Written Informed Consent * Male or female * Age ≥ 18 years and ≤80 years * Normal Retina Healthy subjects

Exclusion criteria

* Glaucoma * Limited Ability for Agreement * Spectrum of retinal diseases * Subjects that may have been exposed to retinal photography in the past 24 hours prior to the study visit or plan to have retinal photography in the 24 hours after the study visit Diseased subjects Inclusion Criteria: * Written Informed Consent * Male or female * Age ≥ 18 years and ≤80 years * Spectrum of retinal diseases Diseased subjects

Design outcomes

Primary

MeasureTime frameDescription
Clinical Evaluation of Retina Camera Images from both Healthy and Diseased Subjectsup to 1 weekAt least 90% of retinal camera images from both retinal cameras will be equivalent

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026